>>>Johnson & Johnson Guides initial FY14 Rev $73.5-74.3B v $73.8Be - conf call Johnson & Johnson Guides initial FY14 Rev $73.5-74.3B v $73.8Be - conf call comments - Sees pharma sales growth to slow this year, offset by faster sales growth in medical devices and consumer goods.